Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo

Cancer Letters

Volumn 231, Issue 1, 2006, Pages 113-122

  Garvin, Stina ^a   Öllinger, Karin ^a   Dabrosin, Charlotta ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Apoptosis; MDA MB 231; Vascular endothelial growth factor; VEGF

Indexed keywords

ANTIINFECTIVE AGENT; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RESVERATROL; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CHEMOTHERAPY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; STILBENES; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS MUSCULUS; VITACEAE;

EID: 28844451969     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.031     Document Type: Article

References (48)

1. G.R. Howe, T. Hirohata, T.G. Hislop, J.M. Iscovich, J.M. Yuan, and K. Katsouyanni Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies J. Natl Cancer Inst. 82 1990 561 569
2. D.P. Rose, A.P. Boyar, and L. Wynder International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption Cancer 58 1986 2363 2371
3. H. Adlercreutz, Y. Mousavi, J. Clark, K. Hockerstedt, E. Hamalainen, and K. Wahala Dietary phytoestrogens and cancer: in vitro and in vivo studies J. Steroid Biochem. Mol. Biol. 41 1992 331 337
4. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, and C.W. Beecher Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
5. B.D. Gehm, J.M. McAndrews, P.Y. Chien, and J.L. Jameson Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor Proc. Natl Acad. Sci. USA 94 1997 14138 14143
6. J.L. Bowers, V.V. Tyulmenkov, S.C. Jernigan, and C.M. Klinge Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta Endocrinology 141 2000 3657 3667
7. A.S. Levenson, K.M. Svoboda, K.M. Pease, S.A. Kaiser, B. Chen, and L.A. Simons Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor Cancer Res. 62 2002 4419 4426
8. K.P. Bhat, D. Lantvit, K. Christov, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models Cancer Res. 61 2001 7456 7463
9. J.P. Basly, F. Marre-Fournier, J.C. Le Bail, G. Habrioux, and A.J. Chulia Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol Life Sci. 66 2000 769 777
10. R. Lu, and G. Serrero Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells J. Cell. Physiol. 179 1999 297 304
11. O.P. Mgbonyebi, J. Russo, and I.H. Russo Antiproliferative effect of synthetic resveratrol on human breast epithelial cells Int. J. Oncol. 12 1998 865 869
12. R.T. Turner, G.L. Evans, M. Zhang, A. Maran, and J.D. Sibonga Is resveratrol an estrogen agonist in growing rats? Endocrinology 140 1999 50 54
13. K.P. Bhat, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol Ann. NY Acad. Sci. 957 2002 210 229
14. J. Folkman What is the evidence that tumors are angiogenesis dependent? J. Natl Cancer Inst. 82 1990 4 6
15. M.A. Gimbrone Jr., R.S. Cotran, S.B. Leapman, and J. Folkman Tumor growth and neovascularization: an experimental model using the rabbit cornea J. Natl Cancer Inst. 52 1974 413 427
16. B. Linderholm, B. Tavelin, K. Grankvist, and R. Henriksson Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma J. Clin. Oncol. 16 1998 3121 3128
17. B. Linderholm, K. Grankvist, N. Wilking, M. Johansson, B. Tavelin, and R. Henriksson Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment J. Clin. Oncol. 18 2000 1423 1431
18. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial J. Am. Med. Assoc. 288 2002 321 333
19. Early Breast Cancer Trialists'Collaborative Group Ovarian ablation in early breast cancer: overview of the randomised trials Lancet 348 1996 1189 1196
20. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 1997 1047 1059
21. H. Yoshiji, D.E. Gomez, M. Shibuya, and U.P. Thorgeirsson Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer Cancer Res. 56 1996 2013 2016
22. J.K. Ruohola, E.M. Valve, M.J. Karkkainen, V. Joukov, K. Alitalo, and P.L. Harkonen Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells Mol. Cell. Endocrinol. 149 1999 29 40
23. C. Dabrosin Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle J. Clin. Endocrinol. Metab. 88 2003 2695 2698
24. C. Dabrosin, P.J. Margetts, and J. Gauldie Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer Int. J. Cancer 107 2003 535 540
25. S. Garvin, and C. Dabrosin Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo Cancer Res. 63 2003 8742 8748
26. R.E. Bachelder, A. Crago, J. Chung, M.A. Wendt, L.M. Shaw, G. Robinson, and A.M. Mercurio Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells Cancer Res. 61 2001 5736 5740
27. J. Ashby, H. Tinwell, W. Pennie, A.N. Brooks, P.A. Lefevre, N. Beresford, and J.P. Sumpter Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effect J. Appl. Toxicol. 19 1999 39 45
28. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1951 265 275
29. L.L. Vindelov, and I.J. Christensen A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis Cytometry 11 1990 753 770
30. J.M. Zdolsek, K. Roberg, and U.T. Brunk Visualization of iron in cultured macrophages: a cytochemical light and electron microscopic study using autometallography Free Radic. Biol. Med. 15 1993 1 11
31. A.M. Schor, N. Pendleton, S. Pazouki, R.L. Smither, J. Morris, and K. Lessan Assessment of vascularity in histological sections: effects of methodology and value as an index of angiogenesis in breast tumours Histochem. J. 30 1998 849 856
32. G. Nunez, M.A. Benedict, Y. Hu, and N. Inohara Caspases: the proteases of the apoptotic pathway Oncogene 17 1998 3237 3245
33. S. Liu, Y. Sugimoto, S.K. Kulp, J. Jiang, H.L. Chang, and K.Y. Park Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha Anticancer Res. 22 2002 3917 3923
34. E.A. Vladusic, A.E. Hornby, F.K. Guerra-Vladusic, J. Lakins, and R. Lupu Expression and regulation of estrogen receptor beta in human breast tumors and cell lines Oncol. Rep. 7 2000 157 167
35. S.A. Fuqua, R. Schiff, I. Parra, W.E. Friedrichs, J.L. Su, and D.D. McKee Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer Cancer Res. 59 1999 5425 5428
36. C. Palmieri, G.J. Cheng, S. Saji, M. Zelada-Hedman, A. Warri, and Z. Weihua Estrogen receptor beta in breast cancer Endocr. Relat. Cancer 9 2002 1 13
37. G. Cheng, Z. Weihua, S. Makinen, S. Makela, S. Saji, and M. Warner A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary Biol. Reprod. 66 2002 77 84
38. M. Obrero, D.V. Yu, and D.J. Shapiro Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen- induced programmed cell death J. Biol. Chem. 277 2002 45695 45703
39. J. Nilsen, G. Mor, and F. Naftolin Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system J. Neurobiol. 43 2000 64 78
40. E. Brakenhielm, R. Cao, and Y. Cao Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes Fed. Am. Soc. Exp. Biol. J. 15 2001 1798 1800
41. E. Pozo-Guisado, A. Alvarez-Barrientos, S. Mulero-Navarro, B. Santiago-Josefat, and P.M. Fernandez-Salguero The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle Biochem. Pharmacol. 64 2002 1375 1386
42. N. Fang, and J.E. Casida Anticancer action of cube insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities Proc. Natl Acad. Sci. USA 95 1998 3380 3384
43. N.J. Sun, S.H. Woo, J.M. Cassady, and R.M. Snapka DNA polymerase topoisomerase II inhibitors from Psoralea corylifolia J. Nat. Prod. 61 1998 362 366
44. A.M. El Mowafy, and M. Alkhalaf Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism Carcinogenesis 24 2003 869 873
45. C. Dabrosin, J. Chen, L. Wang, and L.U. Thompson Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts Cancer Lett. 185 2002 31 37
46. D. Coradini, C. Pellizzaro, A. Speranza, and M.G. Daidone Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens Cell. Mol. Life Sci. 61 2004 76 82
47. L.F. Brown, A.J. Guidi, S.J. Schnitt, W.L. Van De, M.L. Iruela-Arispe, and T.K. Yeo Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast Clin. Cancer Res. 5 1999 1041 1056
48. D. Bagchi, D.K. Das, A. Tosaki, M. Bagchi, and S.C. Kothari Benefits of resveratrol in women's health Drugs Exp. Clin. Res. 27 2001 233 248